NeuroPro Therapeutics
PrivateLast Round
Early Funding
Mar 1, 2024
Total Funding Raised
$38M
Company Overview
NeuroPro Therapeutics operates in Healthcare & Life Sciences and is based in Oregon. Its latest recorded funding round was an Early Funding round in March 2024.
NeuroPro Therapeutics is a biotechnology company that develops proprietary small molecule compounds to treat neurological diseases, including epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroPro Therapeutics Comparables
Compare NeuroPro Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IAMA Therapeutics | 77% | |
| Ovid Therapeutics Inc. | 77% | |
| EpilepsyGTx | 75% |
For institutional investors. Book with your work email.
NeuroPro Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 1, 2024 | ||||
| Early Funding | Feb 1, 2023 |
For institutional investors. Book with your work email.
NeuroPro Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fengate Asset Management | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 69% MoM, reaching 3.2K.
- Jan 20, 2026
Monthly visitors grew 150% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
NeuroPro Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroPro Therapeutics's valuation, stock price, and market status.
Is NeuroPro Therapeutics a public or private company?
NeuroPro Therapeutics is a private company.
What is the current stock price of NeuroPro Therapeutics?
NeuroPro Therapeutics is a private company, so its shares have no public market price. Caplight tracks NeuroPro Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroPro Therapeutics worth (valuation)?
Valuation information for NeuroPro Therapeutics is not publicly available.
Can I buy NeuroPro Therapeutics stock?
NeuroPro Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroPro Therapeutics's last funding round?
NeuroPro Therapeutics's most recent funding round was Early Funding on March 1, 2024.
Who are the main investors in NeuroPro Therapeutics?
Key investors in NeuroPro Therapeutics include Fengate Asset Management.
Will NeuroPro Therapeutics IPO soon?
No public IPO plans have been announced for NeuroPro Therapeutics.
How can I track NeuroPro Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NeuroPro Therapeutics's shares on secondary markets.